Detailed analysis of cytolytic T lymphocytes (CTL)1 at the molecular level has been hampered by the cellular heterogeneity intrinsic to most model systems studied. The development of cloned lines (1, 2) of CTL facilitates both biochemical (3) and genetic (this report) analyses of function.
The procedure for indirect immunofluorescence staining of cells has been previously described (14) . Hybridoma antibodies AT83A and 3.155 were coupled with biotin-suecinimide (Biosearch, San Rafael, Ca.) using the technique described by Bayer and Wilchek (16) . This permitted fluorescein-conjugated avidin (Vector Laboratories, Burlingame, Calif.) to be used as the second step in the indirect staining protocol. The second step for hybridoma antibody 53.5.1 was a fluorescein-conjugated rabbit anti-mouse Ig (17) . For each stain, 106 cells were used and these were maintained at 0°C throughout the staining procedure.
Assay for Cell-mediated Lympholysis (CML).
Cytolytic activity was measured as 51Cr release from labeled target cells. (a) To screen the microwells of a cloning plate (6.4-ram diameter; Costar 3596; Costar, Data Packaging, Cambridge, Mass.) for specific cytolytic activity, such as was done to select for V4, a microcytotoxicity assay using 500 target cells was employed (18) . (b) The conventional cytotoxicity assay using 5,000 target cells is essentially as previously described (19) , except that centrifugation for 60 see at 200 g preceded the 3.5-h incubation at 37°C. This assay was used to compare the cytolytic activity of the variants with that of L3. When either Con A or phytohemagglutin-P (PHA-P; Difco Laboratories, Detroit, Mich.) was used in conjunction with this assay, the final lectin concentration was 10 #g/ml.
Assay for Anti-Lyt-2.2 (2. 43) Blocking of Cytolytic Activity in the Presence or Absence of Con A. L3
cells were treated either with monoclonal antibody 2.43 (anti-Lyt-2.2) or with 20% FCS in DMEM for 30 min at 5°C. The cells were then assayed in a short-term 51Cr-release assay (7) for cytotoxicity against P-815 tumor target cells in the presence (10 #g/ml) or absence of Con A. EDTA (10 mM final concentration) was added after 30 min incubation with P-815 targets at 37°C. Amount of 51Cr released into the supernate was determined at 2 h (total) incubation.
Targets. P-815 is a tumor cell line of DBA/2 (H-2 d) origin. EL4 is a tumor cell line of C57BL/6 (H-2 b) origin. AKR-A is a tumor cell line of AKR (H-2 k) origin. These lines were maintained in tissue culture.
Results
Derivation of Variant V4. After treatment with EMS for 34 h, trypan blue analysis indicated an average of 1.5 × 106 cells/well for two wells not exposed to EMS and an average of 8.5 × 105 cells/well for two wells exposed to EMS. Cells from these wells were cultured at limiting-dilution to determine the relative cloning efficiency of the EMS-treated cells. 10 d after initiating the culture, microwells were scored for proliferating cells and then tested for specific lysis of P-815 in a microcytotoxicity assay. V4 was selected as a well from the EMS-treated group that contained proliferating cells that had no demonstrable specific killing. For the particular dilution which yielded V4, 9 of 16 of the wells had proliferating cells.
Derivation of Variants 243/1 and 243/2. 32 wells that contained L3 cells were treated with EMS as described in Materials and Methods. 12 d after treatment, during which time the cultures were divided twice, the cells were harvested (12 × 106 total) and treated with 2.0 ml of undiluted hybridoma culture supernate 2.43 followed by 1.0 ml of a 1:5 dilution of rabbit complement. Trypan blue analysis indicated 97% killing. The surviving cells were placed in culture for eight days, after which this population (comprised of 1 × 10 n cells) was again treated with 2.5 ml of undiluted hybridoma culture supernate 2.43 followed by 1.0 ml of a 1:5 dilution of rabbit complement. Trypan blue analysis indicated 95% killing. The treated cells were then transferred to 72 wells of a cloning plate. Thirteen days later, 2 of 72 microwells were positive for growth. These two proliferating lines were designated 243/1 and 243/2. The estimated mutation frequency was 3 × 10 -7.
Derivation of Variant AT83A/1. Another 32 wells that contained L3 cells were treated with EMS as described in Materials and Methods. 12 d after treatment, during which time the cultures were divided twice, the cells were harvested (13 X 10 n total) and treated with 2.0 ml of a 1:20 dilution of hybridoma culture supernate AT83A followed by 1.0 ml of a 1:5 dilution of rabbit complement. Trypan blue analysis indicated 95% killing. The surviving cells were placed in culture for 8 d, after which this population (comprised of 3 × 106 cells) was again treated with 6.0 ml of a 1:20 dilution of hybridoma culture supernate AT83A followed by 1.0 ml of a 1:5 dilution of rabbit complement. Trypan blue analysis indicated 100% killing. The treated cells were then transferred to 72 wells of a cloning plate. 13 d later, 13 of 72 microwells were positive for growth. These thirteen proliferating lines were pooled and placed in culture for 7 d, after which one-half of this population (12 × 106 cells) was treated with 12.0 ml of a 1:20 dilution of hybridoma culture supernate AT83A followed by 2.5 ml of a 1:5 dilution of rabbit complement. Trypan blue analysis indicated 60% killing. AT83A/1 was established from an aliquot of the surviving cells. The estimated mutation frequency was 1 × 10 -6.
FACS analysis ( Fig. 1 ) and subsequent antibody-and-complement-mediated ~lCr-release assays, using monoclonal antibody AT83A, over a period of 2 months (data not shown) suggest that AT83A/1 represents a uniformly Thy-1-population of cells. AT83A/1 is currently being cloned.
Surface Phenotype of the Variants. The surface phenotype of the variants was initially probed using an antibody-and-complement-mediated 51Cr-release assay (data not shown). Monoclonal antibodies AT83A, 2.43, and 3.200 were used. The parental line L3 was lysed by each of these antibodies. On the other hand, AT83A/1 was found to be specifically insensitive to AT83A. V4, 243/1, and 243/2 were found to be specifically insensitive to 2.43 and 3.200. At the level of this assay, therefore, it appeared that lines had been derived which had lost specifically either Thy-1 or Lyt-2.
A more rigorous analysis of the surface phenotype was provided by quantitative fluorescence using the FACS. Such an analysis is shown in Figs. 1, 2, and 3. The cells were stained with hybridoma antibodies recognizing either Thy-1.2, Lyt-2, or Lyt-3.2.
From Fig. 1 , it is apparent that anti-Thy-l.2 stained L3, but did not stain AT83A/1. The patterns of reactivity for V4, 243/1, and 243/2 with anti-Thy-1.2 were comparable to that for L3 (data not shown).
The quantitation of the cell surface expression of Lyt-2 by the parental line L3 and the variant lines derived from it is shown in Fig. 2 . It is apparent that anti-Lyt-2 stained L3, but did not react with the amplifier line L2 which had previously been shown to be Lyt-2-(2). The pattern of reactivity for AT83A/1 was comparable to that for L3. On the other hand, the staining profile for V4 was comparable to that for L2; that is, anti-Lyt-2 did not react with V4. 243/1 and 243/2 bound slightly more anti-Lyt-2 than did either L2 or V4. From the intensity of fluorescence, the amount of Lyt-2 on the surface of 243/1 and 243/2 was estimated to be <10% of that found on the surface of the parental line L3. From Fig. 3 , it is apparent that results obtained with anti-Lyt-3.2 mirrored those obtained with anti-Lyt-2 for all cell lines tested. The parental line L3 was positive, whereas L2 and V4 did not bind the anti-Lyt-3.2. Lines 243/1 and 243/2 showed fluorescence slightly above background, but exhibited < 10% of the cell surface Lyt-3.2 expressed on L3.
Cytolytic Activity of the Variants. The parental line L3 specifically lyses targets that express H-2D d alloantigen (2); however, it can be made to lyse irrelevant targets (those not expressing H-2D a) by the appropriate concentration of either Con A or PHA-P. These lectins have been shown to allow the expression of cytolytic activity in the absence of a specific receptor-antigen interaction (20) .
The cytolytic activity of AT83A/1 is similar to that of the parental line L3 (data not shown). It specifically lyses' P-815 (H-2 d) target cells as efficiently as does L3. The irrelevant targets EL4 (H-2 b) and AKR-A (H-2 k) are lysed only in the presence of Con A or PHA-P.
The behavior of variant V4 is very different from that of L3 in that it appears to have lost the capacity to recognize the appropriate antigen. Specifically, in the absence of Con A, V4 lyses the relevant target P-815 at least 100 times less efficiently than does the parental line L3 (Fig. 4) . However, in the presence of Con A, the lytic activity against P-815 is comparable to that of L3. Apparently the intrinsic cytolytic activity of V4 is comparable to that of L3, but V4 is defective in directing this cytolytic activity to the appropriate target. V4 lyses the irrelevant targets EL4 and AKR-A only in the presence of Con A or PHA-P (data not shown).
The behavior of variant 243/1 is similar in general to that of V4 in that it too is defective in lysing the relevant target P-815. However, in the presence of Con A, the lytic activity of 243/1 against P-815 is much less than that of L3 and V4 (Fig. 5) . The behavior of 243/2 is essentially identical to that of 243/1. The basis for this difference between variant V4 and variants 243/1 and 243/2 has not yet been determined, hut it indicates that line V4 is not identical to the lines 243/1 and 243/2.
Blocking of L3 Cytolytic Activity by Monoclonal Antibody 2.43 (Anti-Lyt-2.2) Can be
Circumvented by Inclusion of Con A in the Assay. Monoclonal antibody 2.43 blocks the cytolytic activity of L3 against the relevant target P-815 in the absence of complement (7) . It was of interest to examine whether this blocking is observed when Con A is included in the assay. The results given in Fig. 6 indicate that it is not. Con Amediated lysis of the irrelevant target EL4 by L3 also is not blocked by antibody 2.43 (data not shown). Antibody 2.43 therefore appears to block receptor-mediated, but not lectin-(Con A) mediated, cytolysis by L3. FiG, 6 . Blocking of L3 cytolytic activity by monoclonal antibody 2.43 (anti-Lyt-2.2) can be circumvented by inclusion of Con A in the assay. L3 ceils were treated either with antibody 2.43 (O) or with medium alone (0) and then assayed in a short-term ~lCr-release assay for cytotoxicity against P-815 tumor targets in the presence (...) (10 #g/ml) or absence (--) of Con A.
Discussion
To investigate the role of Lyt-2 and Thy-1 in cytolysis, we have generated, and characterized the cytolytic activity of, variants of the cloned CTL parental line L3 that specifically lack either Lyt-2 or Thy-1. Collectively, the data indicate that neither Lyt-2 nor Lyt-3 is required for the lethal hit, but suggest that Lyt-2 and/or Lyt-3 are required to direct this lethal hit to the appropriate target. The data also suggest that the expression of Lyt-3 on the cell surface is not independent of the expression of Lyt-2. The results also indicate that Thy-1 is not required for cytolysis. Finally, the data presented here demonstrate the feasibility of analyzing CTL function by genetic manipulation of cell lines derived by the procedure used for L3. These points will be expanded upon below.
Variant AT83A/1 has no detectable Thy-1 on its surface. At this point, it is unclear which of the complementation classes of Thy-1-mutants is/are represented by AT83A/1 (21) . In any case, these cells lyse P-815 specifically as well as does the parental line L3. This indicates that Thy-1 is not required for cytolysis.
The precise nature of the lesions leading to the Thy-1-and Lyt-2-/Lyt-3-pheno-types is unclear, although biochemical (3) and genetic analyses should be informative. Specifically, it is unclear how pleiotropic the mutations are. However, it is important to note that the Thy-1-line expresses Lyt-2 and Lyt-3, and the Lyt-2-/Lyt-3-lines express Thy-1. Thus, expression of one set of cell surface antigens characteristic of subpopulations of T lymphocytes is not linked to expression of another cell surface antigen characteristic of all T lymphocytes. Also, FACS analysis using monoclonal antibodies indicates that V4 and L3 express to a comparable extent both T200 and another high-molecular-weight antigen which is present on activated T lymphocytes (M. Sarmiento, manuscript in preparation). Finally it is important to note that the retention of specific killing activity by the Thy-1-line indicates that the loss of specific cytolytic activity by the Lyt-2-/Lyt-3-lines is not a result of a nonspecific effect of EMS mutagenesis. Previous observations that anti-Lyt-2 and anti-Lyt-3 antibodies block CTL activity in the absence of complement did not resolve whether the effect of antibody was on the recognition or the lethal hit stage of cell-mediated cytolysis. The variant cells provide discriminating evidence. Variant V4 demonstrates that the cytolytic deficiency of a Lyt-2-/Lyt-3-CTL variant can be entirely circumvented through employment of conditions (lectins) that do not require a specific receptor-antigen interaction. This places any role of Lyt-2/Lyt-3 in cytolysis before the lethal hit, in the recognition stage (22) . The concomitant loss of specific killing and the Lyt-2/Lyt-3 molecule(s) by at least two independent variant lines, selected for on the basis of different criteria, strengthens this interpretation. So does the observation that monoclonal anti-Lyt-2.2 antibody in the absence of complement blocks receptor-mediated, but not Con A-mediated, cytolysis by L3. Taken together, these data argue strongly that Lyt-2 and/or Lyt-3 are required for an antigen receptor functional in cytolysis. Supporting this interpretation are preliminary investigations of conjugate formation by the method of Glasebrook (23) , which suggest that whereas L3 and AT83A/1 form conjugates with P-815 with comparable efficiency, V4 does not form conjugates (D. P. Dialynas, unpublished observations). The less efficient lectin-mediated cytolysis by 243/1 and 243/2 relative to that by V4 may be a result of the lesion(s) of the former extending either to a deficiency of the appropriate carbohydrate on the cell surface or to a functional loss of unidentified other component(s) required for cytolysis.
The results given here also indicate that at last two independent variant lines concomitantly lost both Lyt-2 and Lyt-3. In the case of 243/1 and 243/2, selection with anti-Lyt-2 monoclonal antibody and complement resulted in the loss of Lyt-3 but not of the other unselected marker Thy-1. Recent FACS analyses using monoclonal antibodies indicate that the parental line L3 expresses the same number of Lyt-2 and Lyt-3 determinants on the cell surface (J. A. Ledbetter and L. A. Herzenberg, personal communication). Collectively these data argue forcefully for a model in which the expression of Lyt-3 on the cell surface is in some way tightly coupled to the expression of Lyt-2 on the cell surface. This is compatible with recent speculation, arising out of an analysis of the structures recognized by anti-Lyt-2 and anti-Lyt-3 antibodies, that either the Lyt-2 and Lyt-3 determinants exist on the same molecule or the Lyt-2 and Lyt-3 molecules are associated as a dimeric complex (24, 
25).
The results presented here suggest a model (5, 8) in which Lyt-2/Lyt-3 corresponds to a constant domain of the antigen receptor on the parental line L3. However, the data cannot discriminate between a model in which the receptor specificity information is associated with the Lyt-2/Lyt-3 molecule(s) or one in which it is associated with another, independent molecule on the cell surface (in which case Lyt-2/Lyt-3 might serve to efficiently couple antigen recognition with cytolysis). The Lyt-2-/Lyt-3-variant lines described here, particularly V4, should facilitate experiments that address this question.
Summary
To investigate the role of Lyt-2 and Thy-1 in cytolysis, we have generated, by ethyl methanesulfonate mutagenesis and selection, variants of the cloned cytolytic T lymphocyte line L3 that specifically lack either Lyt-2 or Thy-1. An analysis of these variants indicates that neither Lyt-2 nor Lyt-3 is responsible for the lethal hit, but suggests that Lyt-2 and/or Lyt-3 are required for an antigen receptor functional in cytolysis. The data also suggest that the expression of Lyt-3 on the cell surface is not independent of the expression of Lyt-2. Finally the data indicate that Thy-1 plays no role in cytolysis.
